Lepu Biopharma
Founded in Jan 2018 by Dr. Pu Zhongjie, Lepu Biotech focuses on tumor immunotherapy, R&D, production, and sales of targeted therapy drugs.
Launch date
Employees
Market cap
€576m
Enterprise valuation
€607m (Public information from Sep 2024)
Share price
HKD2.96 2157.HK
Songjiang District China (HQ)
Authorizing premium user...